• About us
• Contact

Advertisement

Organisation › Details

VantAI (US)

VantAI is at the forefront of applying generative AI technologies to drug discovery. With a cross-disciplinary team of scientists and engineers, VantAI is well suited to power solutions for induced proximity, where the nuance of protein-protein interactions, such as those in protein degradation, has outsized influence on drug success. *

 

	Start	2019-01-01 established
	Group	Roivant (Group)
	Industry	AI-based drug discovery / AI-based drug development
	Industry 2	artificial intelligence (AI) / machine learning (ML)
	Person	Carpenter, Zachary (Zach) (Roivant 202402 CEO + Co-Founder of VantAI)
	Person 2	Kim, Jae Won (Roivant 202402– COO + CFO of VantAI before Orum Therapeutics + Citigroup Healthcare Investment Banking)
	Region	New York, NY
	Country	United States (USA)
	City	10003 New York, NY
		Address record changed: 2024-02-14
Basic data	Employees	n. a.
		* Document for »About Section«: VantAI. (2/13/24). "Press Release: VantAI Enters Collaboration With Bristol Myers Squibb to Accelerate Molecular Glue Drug Discovery Through Artificial Intelligence". New York, NY.
		Record changed: 2024-02-25

Advertisement

More documents for Roivant (Group)

• [1] VantAI. (2/13/24). "Press Release: VantAI Enters Collaboration With Bristol Myers Squibb to Accelerate Molecular Glue Drug Discovery Through Artificial Intelligence". New York, NY....
• [2] VantAI. (2/7/24). "Press Release: VantAI Appoints Jae Won Kim as Chief Operating Officer and Chief Financial Officer". New York, NY....
• [3] Roche. (10/23/23). "Press Release: Roche Enters into a Definitive Agreement to Acquire Telavant". Basel....
• [4] VantAI. (4/20/22). "Press Release: VantAI Forms Research Collaboration with Boehringer Ingelheim to Identify Novel Protein Degraders". new York, NY & Ingelheim....
• [5] Affimed N.V.. (3/31/22). "Press Release: Affimed Reports 2021 Financial Results and Highlights Recent Operational Progress". Heidelberg....
• [6] Roivant Sciences GmbH. (2/26/21). "Press Release: Roivant Grows Computational Drug Discovery Engine with Acquisition of Silicon Therapeutics". New York, NY, Boston, MA & Basel....
• [7] Medigene AG. (11/12/20). "Press Release: Medigene Provides Q3 2020 Update". Planegg-Martinsried....
• [8] Medigene AG. (10/19/20). "Press Release: Medigene and Cytovant Enter into Service Agreement for DC Vaccine Manufacturing Process Development". Planegg-Martinsried....
• [9] Roivant Sciences GmbH. (10/31/19). "Press Release: Sumitomo Dainippon Pharma and Roivant Sciences Sign Definitive Agreement for Strategic Alliance". Tokyo, Osaka, London & Basel....
• [10] Roivant Sciences GmbH. (10/9/19). "Press Release: Parexel and Datavant Enter Multi-Year Strategic Partnership to Enable the Connection of Real-World Data Across All Parexel Clinical Trials". Boston, MA & San Francisco, CA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.